128 related articles for article (PubMed ID: 26858756)
41. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
[No Abstract] [Full Text] [Related]
42. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
Nielsen HJ; Christensen IJ; Brünner N
Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
[TBL] [Abstract][Full Text] [Related]
43. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma.
Kawabata T; Ichikura T; Majima T; Seki S; Chochi K; Takayama E; Hiraide H; Mochizuki H
Cancer; 2001 Oct; 92(8):2050-5. PubMed ID: 11596019
[TBL] [Abstract][Full Text] [Related]
44. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
45. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
46. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator.
Chung YC; Chang YF
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):369-73. PubMed ID: 12655256
[TBL] [Abstract][Full Text] [Related]
47. Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis.
Wang Z; Wu P; Wu D; Zhang Z; Hu G; Zhao S; Lai Y; Huang J
Onco Targets Ther; 2015; 8():3793-801. PubMed ID: 26719707
[TBL] [Abstract][Full Text] [Related]
48. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
49. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
50. Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study.
You W; Yan L; Cai Z; Xie L; Sheng N; Wang G; Wu X; Wang Z
Front Oncol; 2020; 10():671. PubMed ID: 32509572
[No Abstract] [Full Text] [Related]
51. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
Cao X; Yu T; Zhao G; Xiao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
[TBL] [Abstract][Full Text] [Related]
52. Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer.
Wei SC; Liang JT; Tsao PN; Hsieh FJ; Yu SC; Wong JM
Dis Colon Rectum; 2009 Sep; 52(9):1630-6. PubMed ID: 19690493
[TBL] [Abstract][Full Text] [Related]
53. A Retrospective Propensity Score Matched Study of the Preoperative C-Reactive Protein to Albumin Ratio and Prognosis in Patients with Resectable Non-Metastatic Breast Cancer.
Zhou L; Ma S; Balde AI; Han S; Cai Z; Li Z
Med Sci Monit; 2019 Jun; 25():4342-4352. PubMed ID: 31182704
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
55. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer.
Kubo H; Murayama Y; Arita T; Kuriu Y; Nakanishi M; Otsuji E
World J Surg; 2016 Nov; 40(11):2796-2802. PubMed ID: 27307087
[TBL] [Abstract][Full Text] [Related]
56. Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
Anticancer Res; 2020 Mar; 40(3):1651-1659. PubMed ID: 32132070
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer.
Belluco C; Nitti D; Frantz M; Toppan P; Basso D; Plebani M; Lise M; Jessup JM
Ann Surg Oncol; 2000 Mar; 7(2):133-8. PubMed ID: 10761792
[TBL] [Abstract][Full Text] [Related]
58. Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?
Gomceli I; Tez M; Bostanci EB; Ulas M; Turhan N; Kemik AS; Akoglu M
Hepatogastroenterology; 2012; 59(117):1437-40. PubMed ID: 22155858
[TBL] [Abstract][Full Text] [Related]
59. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
60. Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M
Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
